loading

Finanzdaten der Bioaffinity Technologies Inc-Aktie (BIAF)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
13.91%
1.4461
1.2695 1.8536 2.2076 2.3504
Operating Expenses
1.22%
3.7389
3.785 4.4807 5.1541 4.3243
Benefits Costs and Expenses
22.50%
6.494
5.3013 4.5053 5.1745 4.3487
Costs And Expenses
22.50%
6.494
5.3013 4.5053 5.1745 4.3487
Depreciation and Amortization
0.12%
0.1134
0.1132 0.1546 0.1536 0.1513
Operating Income/Loss
8.85%
-2.2928
-2.5156 -2.6271 -2.9466 -1.9739
Nonoperating Income/Loss
81.70%
-2.7551
-1.5162 -0.0246 -0.0203 -0.0244
Income/Loss From Continuing Operations Before Tax
25.20%
-5.0479
-4.0318 -2.6517 -2.9669 -1.9983
Income Tax Expense/Benefit
89.02%
0.00318
0.029 0.0087 - 0.00256
Income/Loss From Continuing Operations After Tax
24.39%
-5.0511
-4.0608 -2.6604 -2.9669 -2.0008
Net Income/Loss
24.39%
-5.0511
-4.0608 -2.6604 -2.9669 -2.0008
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
95.56%
1.0664
24.02 16.26 0.8877 12.39
Diluted Average Shares
95.56%
1.0664
24.02 16.26 0.8877 12.39
Basic Earnings Per Share
2,688%
-4.74
-0.17 -0.16 -0.21 -0.16
Diluted Earnings Per Share
2,688%
-4.74
-0.17 -0.16 -0.21 -0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research LH
$265.31
price up icon 0.87%
diagnostics_research DGX
$200.79
price down icon 0.10%
diagnostics_research MTD
$1,176.70
price up icon 0.59%
$188.84
price down icon 0.09%
diagnostics_research IQV
$165.07
price up icon 1.33%
diagnostics_research WAT
$285.89
price up icon 0.77%
Kapitalisierung:     |  Volumen (24h):